Carl Firth, CEO & Founder, ASLAN pharma, Singapore

Interviewing ASLAN, a leading Singapore biotech

Emily Event News Leave a Comment

If you have been keeping a lookout for promising biotech companies in Asia to invest in, then you have probably heard about ASLAN, a Singapore based biotech company founded in 2010.  Dr Carl Firth, the CEO and founder and his team has worked tirelessly to build innovative therapeutic products focusing on treating patients in Asia, as well as several rare …

Vitalik Buterin, Cofounder of Ethereum speaking at BioPharma Asia Convention 2017, Singapore

How blockchain is disrupting the healthcare industry

Emily Event News Leave a Comment

Blockchain has the potential to improve data transparency and reduce both friction and costs of current intermediaries. While its application is pretty well known in banking and finance industry, the usage of blockchain in healthcare and life sciences field is still new. To give you a better understanding on how this technology will disrupt the healthcare industry, we invited Vitalik …

NIH researchers working on tissue chips for better disease modelling

Tissue chips to enable successful drug development

Emily Event News Leave a Comment

With the high levels of uncertainty when working on live animals and human models, it is unsurprising that approximately 30 percent of promising medications fail in human clinical trials because of their pharmacovigilance properties. Thus, eliminating adverse effects at the earlier stage of drug development process will save costs and time for sponsor companies investing in the research, enabling researchers …


CellProthera on regenerative medicine & global cardiac research

Emily Event News Leave a Comment

Cardiovascular disease is the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. Working on regenerative medicines to treat cardio diseases, CellProthera’s team aim to build a leading company in the field of regenerative medicine and put together every necessary effort to make …

Biopharma-Asia-2017 700x

Keynote speakers announced at BioPharma Asia Convention, Singapore

Emily Event News Leave a Comment

In case you have missed it, the BioPharma Asia 2017 is shaping up to be an exciting event this 21-23 March in Singapore. With over 140 speakers, more than 600 delegates and approximately 1500 attendees already confirmed, we are proud to share with you some of the prominent key speakers who will be joining us in 2 weeks’ time. The future …

Biopolis_Running Man 1600

Biopolis – Asia’s Premier Biomedical Hub

mildred Uncategorised Leave a Comment

  As the lead government agency responsible for the development of industrial infrastructure to support and catalyse the growth of industries and enterprises in Singapore, JTC has pioneered and developed innovative infrastructure solutions to meet the unique needs of the biomedical industry. One of these is Biopolis @ one-north, a world-class, purpose-built biomedical research and development hub. With 13 buildings …

Rare Disease Day – The Fight Against Rare Diseases

mildred Uncategorised Leave a Comment

First launched by EURORDIS and its Council of National Alliances in 2008, Rare Disease Day is now in its 9th year and is recognized in over 80 countries on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on …

Left: Founder Dr Jane Cardosa
Center: Dr Uwe Schlokat
Right: Michelle Gan

Interview with Dr Uwe Schlokat, CEO of Sentinext Therapeutics

Emily Event News Leave a Comment

Founded in 2008, Sentinext is a Malaysian biotech company which focuses on building innovative vaccines to protect Asia populations against infectious viral diseases. Using its proprietary Virus-like particle (VLP technology), Sentinext’s trademark project is to build vaccines for Hand foot mouth disease (HFMD), a highly prevalence infection among children in Asia. We have had the opportunity to interact with its CEO …

Capture 2

Maximizing injectables production: Enabling consistent supply

mildred Uncategorised Leave a Comment

One of the most significant trends today in our industry is the enormous growth of the injectable market. Injectables are becoming the single largest driver of the pharma/biotech market and offer tremendous opportunity. However, bringing an injectable to market is no small feat. Staying competitive, once in the market, can be just as challenging. Market and regulatory requirements regarding safety …

Capture 1

Meeting the inherent challenges of complex drug substances

mildred Uncategorised Leave a Comment

Realizing the full potential of a novel injectable drug compound is no small task. In the months and years that lead from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can slow development to a halt, often at key stages. A careful, systematic approach to identifying where and why these roadblocks …